Latest Biotechnology, Pharmaceutical and Healthcare News

19:12 EDT 5th October 2015 | BioPortfolio

Showing News Articles 1–25 of 410,000+

Monday 5th October 2015

Results from Merck’s Phase 3 Study of Investigational Chronic Hepatitis C Therapy Elbasvir/Grazoprevir in Patients with Advanced Chronic Kidney Disease Published in The Lancet

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the publication of results from C-SURFER, the first Phase 31 clinical trial to investigate an all-oral, ribavirin-free chronic hepatitis C virus (HCV) treatment regimen in treatment-naïve and treatme

Unique Funding Pans Out For Visterra

On the heels of getting a second grant from the Biomedical Advanced Research and Development Authority (BARDA) of the US Department of Health and Human Services (HHS), Visterra Inc. is ready to advance its broad spectrum flu treatment – a drug ...

UPPI LLC (United Pharmacy Partners) Proudly Announces That Thirty-One (31) Nuclear Pharmacy Members & Affiliates Received a Recognition Award from the U.S. Department of Energy

UPPI LLC (United Pharmacy Partners) is proud to announce that thirty-one (31) nuclear pharmacy members and affiliates have received a Recognition Award from the U.S. Department of Energy’s National Nuclear Security Administration (DOE/NNSA) from Assistant Deputy Administrator Peter H. Hanlon in recognition of providing radiopharmaceuticals of molybdenum ...

UnitedHealthcare and Optum Support People Affected by Storms and Flooding in South Carolina

Assistance for UnitedHealthcare plan participants whose access to care or prescriptions may have been affected Free emotional-support help line from Optum open to anyone UnitedHealthcare and Optum, the health benefits and services companies of UnitedHealth Group (NYSE: UNH), are taking immediate action to help people in...

AHF Lauds CA Governor Signing End Of Life Option Act

Today AIDS Healthcare Foundation President Michael Weinstein issued the following statement on California Governor Edmund G. Brown Jr. signing ABX2 15, legislation to allow physicians to provide lethal prescriptions to mentally competent adults suffering from a terminal disease that will, within reasonable medical judgment, result in death within six month...

A randomized phase II study of stem cell mobilization with cyclophosphamide+G-CSF or G-CSF alone after lenalidomide-based induction in multiple myeloma

Influence of melphalan plus fludarabine-conditioning regimen in elderly patients aged ⩾55 years with hematological malignancies

Long-term results of adjuvant donor lymphocyte transfusion in AML after allogeneic stem cell transplantation

Physician-diagnosed depression and suicides in pediatric hematopoietic cell transplant survivors with up to 40 years of follow-up

Early post-transplant contrast-enhanced abdominopelvic CT scan predicts the risk of subsequent acute GvHD

Allogeneic hematopoietic cell transplantation for severe aplastic anemia: similar long-term overall survival after transplantation with related donors compared to unrelated donors

Clinically significant adverse events after major ABO mismatch BMT

The bone marrow microenvironment is similarly impaired in allogeneic hematopoietic stem cell transplantation patients with early and late poor graft function

Cerebrospinal fluid chimerism analysis in patients with neurological symptoms after allogeneic cell transplantation

Diffuse large B-cell lymphoma: is salvage possible after failure of second-line treatment?

Exacerbation of IgA nephropathy following G-CSF administration for PBSC collection: suggestions for better donor screening

Long-term survival outcomes of reduced-intensity allogeneic or autologous transplantation in relapsed grade 3 follicular lymphoma

A randomized controlled trial of cyclosporine and tacrolimus with strict control of blood concentrations after unrelated bone marrow transplantation

Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomes

The impact of pre-transplant body weight on short- and long-term outcomes after allogeneic hematopoietic cell transplantation in adults using different weight classification tools

Decreased pulmonary function in asymptomatic long-term survivors after allogeneic hematopoietic stem cell transplant

FDA Approves ARISTADA™ for Treatment of Schizophrenia

— First Long-Acting Atypical Antipsychotic With Both Once-Monthly and Six-Week Dosing Options — — Product Features Include Range of Dose Strengths and Multiple Dosing Intervals Designed to Address Individual Patient Needs — — Company to Host Conference Call at 7:30 a.m. EDT Tomorrow — Alkermes plc (NASDAQ: ALKS) tod...

Dr. Bruce Crawford Invites Patients with Gum Disease to Improve their Oral Health with Laser Dentistry in St. Petersburg, FL, in Honor of Dental Hygiene Month

Dr. Bruce Crawford recognizes Dental Hygiene Month by inviting patients with gum disease and other common oral ailments to receive laser dentistry in St. Petersburg, FL. The minimally invasive nature of this laser-based treatment, known as the LANAP® protocol, creates a more appealing option compared to traditional methods of gum disease procedures. St. Petersburg, FL (PRWEB) October 05, 2015...

California Gov. Brown Signs Aid-in-Dying Bill Into Law

Brown said that he weighed the controversial issue carefully, and in the end decided that it would be a comfort to know the option was available if he were facing a painful, prolonged death.

Three-dimensional macroporous nanoelectronic networks as minimally invasive brain probes

An ultra-flexible cylindrical mesh embedding multiple electrodes bending away from the device is used to probe rodents’ neural activity in vivo. This geometry improves the neuron–probe contact and reduces tissue response in chronic applications.


BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device information service collates press releases, news articles and blogs from over 275 sources.